Prescribers sourcing AOD-9604 for patients today are working exclusively within the 503A compounding pharmacy framework, which permits individualized preparations but does not confer approval or validated dosing guidance [4]
Determination of these values was based on an RDA of 2.4 g/d for non-pregnant women, plus what will be transferred to the fetus during pregnancy and what will be delivered in breast milk
These numbers matter because GLP-1s slow down digestion and change gut motility, which is why side effects like nausea, constipation, diarrhea, bloating, and gas are so common
More promising results once continued to use may show for more than three months, but feeling energized can already be experienced right after the injection
Fast Visit A focused option when you want a simple wellness injection rather than a longer IV therapy visit